Page 88 - Annual Report
P. 88

HONG KONG ACADEMY OF MEDICINE
                   香港醫學專科學院
                   NOTES TO THE FINANCIAL STATEMENTS
                   FOR THE YEAR ENDED 31 DECEMBER 2020




                   19.  FINANCIAL INSTRUMENTS (Continued)

                       f)   Price risk

                            The Group is exposed to equity price changes arising from listed equity investments.
                            The  Group’s  listed  investments  are  listed  on  recognised  stock  exchange.  Listed
                            investments held in the investments in equity instruments designated at FVOCI have
                            been chosen based on their longer term growth potential and are monitored regularly for
                            performance against expectations.

                            The Council monitors the market price risk of the investments individually and estimated
                            that a 5% increase/decrease in market prices of equity securities at 31 December 2020,
                            with all other variables held constant, would decrease/increase the Group’s deficit for
                            the year (and increase/decrease the Group’s general fund) and increase/decrease the
                            Group’s other components of reserve by HK$nil and HK$274,000 respectively (2019:
                            HK$nil and HK$1.7 million respectively).


                   20.  CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS

                       The  following  are  the  key  assumptions  concerning  the  future,  and  other  key  sources  of
                       estimation uncertainty at the end of the reporting period, that have a significant risk of causing
                       a material adjustment to the carrying amounts of assets and liabilities within the next reporting
                       period.

                       a)   Useful lives of property, plant and equipment

                            The Group determines the estimated useful lives and related depreciation charges for its
                            items  of  property,  plant  and  equipment.  This  estimate  is  based  on  the  historical
                            experience of the actual useful lives of items of property, plant and equipment of similar
                            nature and functions. Management will revise the depreciation charge where useful lives
                            are  different  to  the  ones  previously  estimated,  and  it  will  write-off  or  write-down
                            technically obsolete or non-strategic assets that have been abandoned or sold.

                       b)   Measurement of the ECLs for receivables

                            The  measurement  of  the  expected  loss  allowance  for  receivables  is  an  area  that
                            requires the use of complex models and significant assumptions about future economic
                            conditions  and  credit  behavior  (the  likelihood  of  debtors  defaulting  and  the  resulting
                            losses). Further details are set out in note 19(a) Credit Risk.

















                                                           32





          86   HKAM Annual Report 2021
   83   84   85   86   87   88   89   90   91   92   93